P2.03-023 Characteristics of NSCLC Patients Treated in First Line Treatment with Tyrosine Kinase Inhibitors (TKI) - Real Data from the Czech Republic
| Autor: | Skrickova, J., Chloupkova, R., Bortlicek, Z., Pesek, M., Kolek, V., Hejduk, K., Koubkova, L., Cernovska, M., Krejci, J., Zemanová, M., Havel, L., Roubec, J., Hrnciarik, M., Salajka, F., Coupkova, H., Satankova, M., Benejova, A., Grygarkova, I., Opalka, P., Sixtova, D. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S2136-S2136 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|